Back to Search
Start Over
Identification ofHaemophilus haemolyticusin clinical samples and characterization of their mechanisms of antimicrobial resistance
- Source :
- Journal of Antimicrobial Chemotherapy. 71:80-84
- Publication Year :
- 2015
- Publisher :
- Oxford University Press (OUP), 2015.
-
Abstract
- Objectives The objectives of this study were to establish the frequency of Haemophilus haemolyticus in clinical samples, to determine the antimicrobial resistance rate and to identify the mechanisms of resistance to β-lactams and quinolones. Methods An updated database was used to differentiate between MALDI-TOF MS results for Haemophilus influenzae and H. haemolyticus. Antimicrobial susceptibility was studied by microdilution, following EUCAST criteria. The β-lactamase types were identified by PCR analysis of isolates that tested positive for nitrocefin hydrolysis. Mutations in the ftsI gene were identified in isolates with ampicillin MICs ≥0.25 mg/L. Mutations in the quinolone resistance-determining region (QRDR) were identified in isolates with ciprofloxacin MICs ≥0.5 mg/L. Results Overall, we identified 69 H. haemolyticus isolates from 1706 clinical isolates of Haemophilus spp. from respiratory, genital, invasive, and other infection sources. The frequency of H. haemolyticus was low in respiratory samples compared with that of H. influenzae, but in genital-related samples, the frequency was similar to that of H. influenzae. We found low antimicrobial resistance rates among H. haemolyticus isolates, with 8.7% for ampicillin, 8.7% for co-trimoxazole, 7.2% for tetracycline and 4.3% for ciprofloxacin. Mutations in the ftsI gene classified the isolates into four groups, including the newly described Group Hhae IV, which presents mutations in the ftsI gene not identified in H. influenzae and H. haemolyticus type strains. Three ciprofloxacin-resistant H. haemolyticus isolates with mutations affecting GyrA and ParC were identified. Conclusions The frequency of H. haemolyticus was low, especially in respiratory samples, where H. influenzae is the main pathogen of this genus. Although antimicrobial resistance rates were low, three ciprofloxacin-resistant H. haemolyticus clinical isolates have been identified for the first time.
- Subjects :
- Adult
0301 basic medicine
Microbiology (medical)
Haemophilus Infections
medicine.medical_treatment
030106 microbiology
Haemophilus
Microbial Sensitivity Tests
Drug resistance
Quinolones
beta-Lactams
medicine.disease_cause
Polymerase Chain Reaction
beta-Lactamases
Microbiology
Haemophilus influenzae
03 medical and health sciences
Antibiotic resistance
Ampicillin
Drug Resistance, Bacterial
medicine
Humans
Nitrocefin
Pharmacology (medical)
Pharmacology
biology
biochemical phenomena, metabolism, and nutrition
bacterial infections and mycoses
biology.organism_classification
Virology
Anti-Bacterial Agents
Infectious Diseases
Haemophilus haemolyticus
Genes, Bacterial
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
Beta-lactamase
medicine.drug
Subjects
Details
- ISSN :
- 14602091 and 03057453
- Volume :
- 71
- Database :
- OpenAIRE
- Journal :
- Journal of Antimicrobial Chemotherapy
- Accession number :
- edsair.doi.dedup.....eb075985215dc3ab779eac9cb78a6b9e
- Full Text :
- https://doi.org/10.1093/jac/dkv307